KidneyIntelX
For Providers
KidneyIntelX:
Don't Miss Another Patient's Kidney Failure
Patients living with diabetes face numerous comorbidities, including diabetic kidney disease. Traditional clinical tools are unable to identify which of the one in five adults with early diabetic kidney disease is at the highest risk of progressing toward kidney failure.
The KidneyIntelX diagnostic is a new standard of care for diabetic patients. With 90% accuracy, KidneyIntelX enables providers to focus kidney care on patients most at risk.
Proven Diagnostic. Actionable Insight.
A standard blood draw
KidneyIntelX is as simple to order as a standard creatinine test and can be incorporated into your regular care plan
Advanced risk identification
KidneyIntelX provides a simple score that indicates near term risk of kidney failure. You will confidently know which of your patients require greater attention
Maintain
Low
Low-risk patients are not likely to progress toward end-stage kidney disease and should continue to be monitored by their doctor every year
Monitor
Intermediate
Intermediate-risk patients require more primary care follow up (two to three times per year) and may need a referral to a specialist
Act
High
High-risk patients are significantly more likely to progress toward end-stage kidney disease and require more aggressive care, potentially including a referral to a specialist
Learn More
Now Available: UACR
Urine Albumin to Creatinine Ratio Test
UACR is used to diagnose, stage, monitor and help define a treatment plan for kidney disease.
Recently, UACR became a Kidney Health Evaluation HEDIS (Healthcare Effectiveness Data and Information Set) measure, the result of a large multi-disciplinary, multi-stakeholder technical expert panel of government and healthcare experts. The measure is aimed at improving UACR testing in people with diabetes, which is a high-risk factor for developing kidney disease.
Clinical guidelines also recommend that UACR be routinely tested in people with diabetes to diagnose kidney disease.